WEE1 and cancer: Despite the search for those molecularly targeted drugs capable of inhibiting the activity of protein kinases involved in cancer-specific features, a lack of efficacy in tumor progression or patient survival has been observed in several clinical trials using target-oriented anti-cancer compounds [56,57].